Paraneoplastic Neurological Syndromes
Paraneoplastic neurological disorders are rare debilitating neurological illnesses associated with remote effects of a malignant neoplasm (e.g., small cell lung cancer, breast and gynaecological tumours). Very often the symptoms precede the detection of the paraneoplastic tumours.
CLS offers a comprehensive panel of neurology tests to aid in diagnosis of various autoimmune mediated neuropathies and paraneoplastic with confirmation for the most common markers. IFA on cerebellar tissue is the initial screen for anti-neuronal antibodies and Blot assys are used to confirm the specificities. Paraneoplastic neurological antibodies that target neuronal nuclei of the central nervous system are anti-Hu (ANNA-1), anti-Ri (ANNA-2), ANNA-3 and anti-Ma. Paraneoplastic neurological antibodies that target antigens in the cytoplasm of the Purkinje cell are anti-Yo (PCA1), PCA2 and anti-Tr (PCA-Tr). Other paraneoplastic neurological antibodies are anti-amphiphysin, anti-CV2/CRMP5, anti-GAD65 and anti-Zic4, all of which are measured using the PNS11 Diver assay.
Myelin Associated Antibodies (MAG)
Antibodies to myelin proteins are associated with demyelinative diseases such as multiple sclerosis and peripheral neuropathy. Detection is usually performed by Western Blot or LineBlot assays which are available through CLS.
Myasthenia Gravis (MG)
Myasthenia Gravis (MG) is a disorder in which autoantibodies to acetylcholine receptors (AChR) at the neurmuscular junction of the skeletal muscle lead to AChR loss and muscle weakness.
The ElisaRSR™ AChR Ab Acetylcholine Receptor (AChR) Autoantibody Elisa Kit is for the quantitative determination of autoantibodies to acetylcholine receptor in serum. Suitable for both foetal and adult AChR in MG.
ACE/96: ElisaRSR™ AChR Ab - download the datasheet.
|Code||Description||MSDS||Instructions for use|
|ACE/96||ElisaRSR™ AChR Ab Elisa Kit|
|PNS11 Diver||PNS11 Diver Blot IgG|